T. Robak
Department of Hematology
Medical University of Lódź
Poland
Name/email consistency: high
- Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies. Robak, T., Góra-Tybor, J., Lech-Marańda, E., Błoński, J.Z., Kasznicki, M. Eur. J. Haematol. (2001)
- Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?. Robak, T., Błoński, J.Z., Kasznicki, M. Leuk. Lymphoma (2001)
- Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus. Robak, T., Robak, E., Bartkowiak, J., Błoński, J.Z., Niewiadomska, H., Wawrzyniak, E. Leuk. Lymphoma (2001)
- Cladribine in the treatment of chronic lymphocytic leukemia. Robak, T. Leuk. Lymphoma (2001)
- Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur. Robak, T., Kasznicki, M., Bartkowiak, J., Kordek, R., Wawrzyniak, E., Błonski, J.Z. Leuk. Lymphoma (2001)
- Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia. Robak, T., Wrzesień-Kuś, A., Lech-Marańda, E., Kowal, M., Dmoszyńska, A. Leuk. Lymphoma (2000)
- Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. Robak, T., Bloński, J.Z., Kasznicki, M., Blasińska-Morawiec, M., Krykowski, E., Dmoszyńska, A., Mrugala-Spiewak, H., Skotnicki, A.B., Nowak, W., Konopka, L., Ceglarek, B., Maj, S., Dwilewicz-Trojaczek, J., Hellmann, A., Urasiński, I., Zdziarska, B., Kotlarek-Haus, S., Potoczek, S., Grieb, P. Blood (2000)
- Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388. Robak, T., Szmigielska, A. Neoplasma (2000)
- 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia. Robak, T., Błasińska-Morawiec, M., Błoński, J.Z., Dmoszyńska, A. Leuk. Lymphoma (1999)
- Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia. Robak, T., Kasznicki, M., Strzelecka, B., Bartkowiak, J., Debiec-Rychter, M. Leuk. Lymphoma (1999)
- Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission. Robak, T., Wierzbowska, A., Błasińska-Morawiec, M., Korycka, A., Błoński, J.Z. Mediators Inflamm. (1999)
